The sixth meeting of the Monitoring Committee of Lord's Mark Industries Limited (formerly known as Kratos Energy & Infrastructure Limited) was held on April 28, 2026, at the office of the Erstwhile Resolution Professional in Nagpur, conducted online via Zoom. The meeting was chaired by CA. Amit C. Poddar, Erstwhile Resolution Professional (RP), and commenced at 12:45 PM, concluding at 1:00 PM. The proceedings covered several significant agenda items related to the company's ongoing insolvency resolution process, share listing, and management transition.

Meeting Attendance

The following members and invitees participated in the sixth Monitoring Committee meeting:

BSE Listing and Trading Update

The Erstwhile RP apprised the members that the Corporate Debtor had been actively following up with officials of the Bombay Stock Exchange (BSE) for the listing of its shares. BSE officials had sought various documents, some of which were submitted earlier, following which additional documents were requested. The Corporate Debtor subsequently approached Justice J.P. Devadhar to obtain a legal opinion on the mandatory and non-mandatory requirements for listing.

A legal opinion dated 27.03.2026 was submitted to BSE along with the requisite documents, upon which BSE expressed satisfaction and assured that the equity shares of the Corporate Debtor would be listed, with trading expected to commence shortly. Mr. Sachidanand Upadhyay further confirmed that he had visited the BSE office on multiple occasions and the Securities and Exchange Board of India (SEBI) office once, and that BSE had confirmed trading would commence shortly after receipt of confirmation from SEBI.

Management Handover and Trading Commencement

The Monitoring Committee unanimously approved the handover of management and control to the reconstituted Board of Directors for carrying out regular affairs of the Corporate Debtor, immediately upon commencement of trading scheduled for 5th June 2026 (approx.). The resolution was passed with 100% voting in favour. The Erstwhile RP also confirmed that intimation regarding the scheduled date of commencement of listing and trading would be filed on the BSE portal and communicated via email.

Share Allotment in Approved Swap Ratio

The Erstwhile RP informed the members of the planned equity share allotment to eligible shareholders of erstwhile Lord's Mark Industries Limited. Key details of the allotment are as follows:

The Erstwhile RP stated that intimation regarding the above allotment in the approved swap ratio would be filed on the BSE portal and communicated via email.

Warrant Conversion and Independent Director Appointment

The Monitoring Committee unanimously approved, with 100% voting in favour, the conversion of all pending warrants in the name of erstwhile Lord's Mark Industries Limited into equity shares of Lord's Mark Industries Limited, immediately post listing and commencement of trading, as per norms of the exchange. Mr. Sachidanand Upadhyay clarified that this conversion would not be as per the Resolution Plan but would be carried out in accordance with stock exchange norms, resulting in an increase in the share capital of the Corporate Debtor.

The reconstituted Board of Directors was also granted liberty to appoint independent directors in line with the provisions of the Companies Act, as it deemed fit, with a proposed declaration and implementation on or before 5th June 2026. Mr. Sachidanand Upadhyay assured that he would send intimation to the Erstwhile RP with the name of the proposed Independent Director via email.

Expense Ratification for Monitoring Period

The Monitoring Committee ratified the expenses incurred by the Erstwhile RP for the period from 03.01.2026 to 27.04.2026, which primarily comprised RP fees. The detailed expense statement is set out below:

The Monitoring Committee unanimously approved the total expenses of Rs. 9,44,000/- for the period from 03.01.2026 to 27.04.2026, with 100% voting in favour of the resolution. With no further business to transact, the meeting concluded at 1:00 PM. The minutes were digitally signed by CA. Amit C. Poddar on 05.05.2026.

Lord's Mark Industries Limited has achieved a significant milestone in the healthcare sector with the launch of the world's first cost-optimised AI-powered hemodialysis centre at Shakti Hospital, Ahmedabad. The development was disclosed to stock exchanges pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, dated 04th May 2026. At the heart of this centre is the Lord's Renal Renalyx Machine, described as India's first indigenously developed smart AI-based cost-effective hemodialysis system, reinforcing the country's Make in India initiative in advanced medical device manufacturing.

Technology and Clinical Features

The Renalyx Machine integrates AI, IoT, and cloud connectivity to deliver real-time monitoring and predictive clinical insights. The system is equipped with a comprehensive set of clinical capabilities designed to enhance patient outcomes and operational efficiency. Key features of the machine include:

• Personalized dialysis protocols tailored to individual patient needs
• Kt/V tracking for precise dialysis adequacy measurement
• Precise fluid management to ensure patient safety
• Endotoxin filtration for enhanced infection control
• Remote supervision and centralized data access for healthcare providers

The following table summarizes the key parameters of the newly launched centre and the Renalyx Machine:

Strategic and Commercial Impact

The launch carries significant strategic implications for both the company and India's broader medical device ecosystem. By deploying an indigenously developed machine, Lord's Mark Industries aims to reduce the country's dependency on imported dialysis equipment while lowering the total cost of ownership for healthcare providers. The centre is designed for cost efficiency, scalability, and improved clinical outcomes, positioning it as a replicable model for wider deployment across hospitals and dialysis centres nationwide.

On the commercial front, the company has outlined an ambitious expansion roadmap. It plans to establish 50 dialysis centres by March 2027, in addition to pursuing domestic sales and exports of the Renalyx Machine. The company is also in the process of obtaining US FDA approval, which is expected to support its global expansion strategy.

Management Commentary

Mr. Sachidanand Upadhyay, Managing Director of Lord's Mark Industries Limited, commented on the development:

"The Lord's Renal Renalyx Machine represents a fundamental shift in dialysis care by combining intelligent technology, indigenous manufacturing, and affordability. Our vision is to enable scalable, high-quality treatment while positioning India as a global leader in AI-based medical devices."

The launch underscores the company's continued focus on innovation, healthcare accessibility, and technology-driven growth, marking a notable step in its evolution within the advanced medical devices segment.